Fulcrum Pharma plc (AIM: FUL), the drug development and strategic outsourcing services company, is pleased to announce the appointment of Dr Bruce McCreedy, the Chief Executive Officer of Fulcrum’s US subsidiary, to the Company’s Board.
Fulcrum Pharma plc (AIM: FUL), the drug development and strategic outsourcing services company, is pleased to announce the appointment of Dr Bruce McCreedy, the Chief Executive Officer of Fulcrum’s US subsidiary, to the Company’s Board.
